Chat with us
👋 Any questions?
Please text us at
(833) 400-3868

UPGUYS Ranked No. 4 on The Globe and Mail's 2026 Canada's Top Growing Companies, Second Consecutive Year in the Top 10

UPGUYS newsroom

Men's longevity and hormone optimization platform with pharmacy services posts 5,308% three-year revenue growth; co-founders named 2026 EY Entrepreneur Of The Year® Pacific Region finalists.

BURNABY, BC, November 9, 2026 – UPGUYS Health Inc., the Canadian men's longevity and hormone optimization platform with pharmacy services co-founded by Mat Rezaei and Ramin Behzadi, has been ranked No. 4 on The Globe and Mail's 2026 Report on Business ranking of Canada's Top Growing Companies, with three-year revenue growth of 5,308%. It is the company's second consecutive year in the top 10, after placing No. 8 in 2025. UPGUYS has served more than 200,000 Canadian patients through Canadian-licensed practitioners and two licensed Canadian pharmacies.

Canada's Top Growing Companies is an editorial ranking published annually by The Globe and Mail's Report on Business magazine. It ranks Canadian companies on three-year revenue growth. Companies apply voluntarily and must meet revenue requirements to qualify. In 2026, 375 companies earned a place on the list, down from 400 in 2025. The full ranking is published in the October issue of Report on Business magazine and online at theglobeandmail.com. The Globe lists UPGUYS Health Inc. as a Burnaby, B.C. private company in the Health care & Wellness category, with 65 employees and 2025 revenue between $25 million and $50 million.

UPGUYS provides low testosterone treatment in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan, and related men's health care in 12 Canadian provinces and territories. Low testosterone treatment, sometimes called testosterone replacement therapy (TRT), begins with a symptom review and morning blood tests. A licensed practitioner determines whether treatment is appropriate for each patient. Care is delivered by a network of Canadian-licensed practitioners led by Medical Director Dr. Dimitre Ranev, and medication is dispensed by two licensed Canadian pharmacies, in Burnaby, BC and Toronto, ON.

The ranking lands in November, when men's health is in focus across Canada through campaigns such as Movember. Many Canadian men do not have a regular family doctor. UPGUYS was built to make the first step easier: an online symptom review, a lab requisition for local blood tests, and a phone consultation with a licensed practitioner, with medication dispensed from a licensed Canadian pharmacy when treatment is prescribed.

The Globe and Mail ranking follows the June 2026 announcement that co-founders Mat Rezaei and Ramin Behzadi were named 2026 EY Entrepreneur Of The Year® Pacific Region finalists.

"Moving from No. 8 to No. 4 in one year shows how many Canadian men were looking for a clear, licensed way to have low testosterone assessed. More than 200,000 patients have now trusted UPGUYS with their care, and every one of them is seen by a Canadian-licensed practitioner and served by our own licensed Canadian pharmacies," said Mat Rezaei, Co-Founder and CEO of UPGUYS Health Inc.

"Growth only matters if the care behind it holds up. Every UPGUYS patient starts with a symptom review and morning blood tests, a licensed practitioner decides whether treatment is appropriate, and follow-up blood work is part of ongoing care. That standard has not changed from our first patient to our 200,000th," said Ramin Behzadi, Co-Founder and CSO of UPGUYS Health Inc.

About UPGUYS Health

UPGUYS is a Canadian men's longevity and hormone optimization platform with pharmacy services. Founded in 2019 and headquartered in Burnaby, British Columbia, UPGUYS serves patients in 12 Canadian provinces and territories through a network of Canadian-licensed practitioners and two licensed Canadian pharmacies, in Burnaby, BC and Toronto, ON. UPGUYS has served more than 200,000 Canadian patients. UPGUYS provides low testosterone treatment, available in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan, and related men's health care. Low testosterone treatment, sometimes called testosterone replacement therapy (TRT), begins with a symptom review and morning blood tests; a licensed practitioner determines whether treatment is appropriate for each patient. UPGUYS was ranked No. 4 on The Globe and Mail's 2026 Canada's Top Growing Companies list, with three-year revenue growth of 5,308%, its second consecutive year in the top 10. Its pharmacies are licensed by the College of Pharmacists of British Columbia (licence 38287) and accredited by the Ontario College of Pharmacists (accreditation 309322), and the company is LegitScript-certified. Learn more at upguys.com.

UPGUYS is part of UPGUYS Health Inc., whose brand portfolio includes UPGUYS (men's health), Everbliss (women's health), UPRX (licensed pharmacies), Upclinic (telehealth), and Uphealth Pharma (pharmaceutical contract manufacturing).

Published by UPGUYS.

All press releases